Adjuvant Sintilimab with or without Anti-VEGF Therapy After Resection in Hepatocellular Carcinoma with Microvascular Invasion: A Multicenter Retrospective Study.

J Hepatocell Carcinoma · 2025 · PMC12717793 · PMID 41427117

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

However, preliminary data suggest a favorable trend in the PD-1 and PD-1+VEGF groups compared to the Surg-only group.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.